BONUS!!! Download part of EduDump CIC dumps for free: https://drive.google.com/open?id=1vg75qVCoCJwOJQyQCAPRLbPP7Pa7UDBr
The EduDump CIC exam questions are real, valid, and updated CIC exam questions that assist you in exam preparation and finally, you will be ready to pass the challenging CIC exam with good scores. The EduDump CIC exam questions are designed and verified by experienced and certified CBIC CIC Exam trainers. They check and verified the answers of all CIC exam questions thoroughly and ensure the top standard of CIC exam questions.
| Section | Objectives |
|---|---|
| Surveillance and Epidemiologic Investigation | - Data collection and analysis - Healthcare-associated infection surveillance methods - Outbreak investigation and response |
| Cleaning, Disinfection, and Sterilization | - Environmental cleaning standards - High-level disinfection practices - Sterilization methods and validation |
| Environment of Care | - Air and water quality management - Healthcare facility design and risk reduction |
| Education, Consultation, and Research | - Staff education strategies - Evidence-based practice and guideline interpretation |
| Infection Prevention and Control Program Management | - Policy and guideline implementation - Program development and leadership - Regulatory compliance |
| Identification of Infectious Disease Processes | - Chain of infection and transmission routes - Host susceptibility factors - Pathogenesis of infectious diseases |
| Occupational Health | - Healthcare worker exposure prevention - Immunization and post-exposure protocols |
The CIC pdf format of the EduDump product is easy-to-use. It contains actual CBIC Certified Infection Control Exam (CIC) exam questions. You can easily download and use CBIC CIC pdf on laptops, tablets, and smartphones. EduDump regularly updates CIC Exam Questions' pdf version so that you always have the latest material. Furthermore, the CBIC CIC pdf can be printed enabling paper study.
NEW QUESTION # 244
The Infection Prevention and Control Committee is concerned about an outbreak of Serratia marcescens in the intensive care unit. If an environmental source is suspected, the BEST method to validate this suspicion is to
Answer: C
Explanation:
The correct answer is C, "obtain surface cultures," as this is the best method to validate the suspicion of an environmental source for an outbreak of Serratia marcescens in the intensive care unit (ICU). According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, Serratia marcescens is an opportunistic gram-negative bacterium commonly associated with healthcare-associated infections (HAIs), often linked to contaminated water, medical equipment, or environmental surfaces in ICUs. Obtaining surface cultures allows the infection preventionist (IP) to directly test environmental samples (e.g., from sinks, ventilators, or countertops) for the presence of Serratia marcescens, providing microbiological evidence to confirm or rule out an environmental source (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.2 - Analyze surveillance data). This method is considered the gold standard for outbreak investigations when an environmental reservoir is suspected, as it offers specific pathogen identification and supports targeted interventions.
Option A (apply fluorescent gel) is a technique used to assess cleaning efficacy by highlighting areas missed during disinfection, but it does not directly identify the presence of Serratia marcescens or confirm an environmental source. Option B (use ATP system) measures adenosine triphosphate (ATP) to evaluate surface cleanliness and organic residue, which can indicate poor cleaning practices, but it is not specific to detecting Serratia marcescens and lacks the diagnostic precision of cultures. Option D (perform direct practice observation) is valuable for assessing staff adherence to infection control protocols, but it addresses human factors rather than directly validating an environmental source, making it less relevant as the initial step in this context.
The focus on obtaining surface cultures aligns with CBIC's emphasis on using evidence-based methods to investigate and control HAIs, enabling the IP to collaborate with the committee to pinpoint the source and implement corrective measures (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.3 - Identify risk factors for healthcare-associated infections). This approach is supported by CDC guidelines for outbreak investigations, which prioritize microbiological sampling to guide environmental control strategies (CDC Guidelines for Environmental Infection Control in Healthcare Facilities, 2019).
References: CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competencies 2.2 - Analyze surveillance data, 2.3 - Identify risk factors for healthcare-associated infections.
CDC Guidelines for Environmental Infection Control in Healthcare Facilities, 2019.
NEW QUESTION # 245
Which of the following measures has NOT been demonstrated to reduce the risk of surgical site infections?
Answer: A
Explanation:
There is no strong evidence that isolating infected cases in a separate surgical suite reduces SSI risk.
Step-by-Step Justification:
* SSI Prevention Strategies Supported by Evidence:
* Preoperative hospital stay limitation reduces exposure to hospital-acquired pathogens.
* Antimicrobial preoperative scrubs lower bacterial load on the skin.
* Adequate nutrition improves immune function and wound healing.
* Why Designating a Separate Surgical Suite Is Not Effective:
* Operating room environmental controls (e.g., laminar airflow, sterilization protocols) are more important than suite designation.
* No significant reduction in SSIs has been observed by segregating infected cases into specific OR suites.
Why Other Options Are Correct:
* A. Limiting preoperative hospital stay: Reduces nosocomial bacterial exposure.
* B. Antimicrobial preoperative scrub: Decreases skin flora contamination.
* C. Assuring adequate patient nutrition: Enhances immune defense against infections.
CBIC Infection Control References:
* APIC Text, "Surgical Site Infection Prevention Strategies".
NEW QUESTION # 246
Which of the following individuals should be excluded from receiving live attenuated influenza virus?
Answer: A
Explanation:
The correct answer is A, "Pregnant persons," as they should be excluded from receiving the live attenuated influenza virus (LAIV) vaccine. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, which align with recommendations from the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP), the LAIV, commonly known as the nasal spray flu vaccine, contains a live attenuated form of the influenza virus. This vaccine is contraindicated in pregnant individuals due to the theoretical risk of the attenuated virus replicating and potentially harming the fetus, despite limited evidence of adverse outcomes (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.2 - Implement measures to prevent transmission of infectious agents).
Pregnant persons are instead recommended to receive the inactivated influenza vaccine (IIV), which is considered safe during pregnancy.
Option B (healthy persons aged 2 to 49) is incorrect because this group is generally eligible to receive LAIV, provided they have no other contraindications, as the vaccine is approved for healthy, non-pregnant individuals in this age range (CDC Immunization Schedules, 2024). Option C (persons with allergies to chicken feathers) is not a contraindication for LAIV; the vaccine is produced in eggs, and while egg allergy was historically a concern, current guidelines indicate that LAIV can be administered to persons with egg allergies if they can tolerate egg in their diet, with precautions managed by healthcare providers. Option D (persons simultaneously receiving an inactivated vaccine) is also incorrect, as LAIV can be co-administered with inactivated vaccines without issue, according to ACIP recommendations, as there is no significant interference between the two vaccine types.
The exclusion of pregnant persons reflects CBIC's emphasis on tailoring infection prevention strategies, including vaccination programs, to protect vulnerable populations while minimizing risks (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.1 - Collaborate with organizational leaders). This decision is based on precautionary principles outlined in CDC and ACIP guidelines to ensure maternal and fetal safety (CDC Prevention and Control of Seasonal Influenza with Vaccines, 2023).
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.1 - Collaborate with organizational leaders, 3.2 - Implement measures to prevent transmission of infectious agents. CDC Prevention and Control of Seasonal Influenza with Vaccines, 2023. CDC Immunization Schedules, 2024.
NEW QUESTION # 247
Which of the following infectious diseases is associated with environmental fungi?
Answer: C
Explanation:
The correct answer is C, "Mucormycosis," as it is the infectious disease associated with environmental fungi.
According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, mucormycosis is caused by fungi belonging to the order Mucorales, which are commonly found in the environment, including soil, decaying organic matter, and contaminated water. These fungi can become opportunistic pathogens, particularly in immunocompromised individuals, leading to severe infections such as rhinocerebral, pulmonary, or cutaneous mucormycosis (CBIC Practice Analysis, 2022, Domain I:
Identification of Infectious Disease Processes, Competency 1.1 - Identify infectious disease processes).
Environmental exposure, such as inhalation of fungal spores or contact with contaminated materials, is a primary mode of transmission, making it directly linked to environmental fungi.
Option A (Listeriosis) is caused by the bacterium Listeria monocytogenes, typically associated with contaminated food products (e.g., unpasteurized dairy or deli meats) rather than environmental fungi. Option B (Hantavirus) is a viral infection transmitted through contact with rodent excreta, not fungi, and is linked to environmental reservoirs like rodent-infested areas. Option D (Campylobacter) is a bacterial infection caused by Campylobacter species, often associated with undercooked poultry or contaminated water, and is not related to fungi.
The association of mucormycosis with environmental fungi underscores the importance of infection prevention strategies, such as controlling environmental contamination and protecting vulnerable patients, which aligns with CBIC's focus on identifying and mitigating risks from infectious agents in healthcare settings (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.2 - Implement measures to prevent transmission of infectious agents). This knowledge is critical for infection preventionists to guide environmental cleaning and patient care protocols.
References: CBIC Practice Analysis, 2022, Domain I: Identification of Infectious Disease Processes, Competency 1.1 - Identify infectious disease processes; Domain III: Infection Prevention and Control, Competency 3.2 - Implement measures to prevent transmission of infectious agents.
NEW QUESTION # 248
The infection preventionist (IP) collaborates with the Intravenous Therapy team to select the best antiseptic for use during the insertion of an intravascular device for adults. For a patient with no contraindications, what antiseptic should the IP suggest?
Answer: D
Explanation:
The selection of an appropriate antiseptic for the insertion of an intravascular device (e.g., peripheral or central venous catheters) is a critical infection prevention measure to reduce the risk of catheter-related bloodstream infections (CRBSIs). The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes evidence-based practices in the "Prevention and Control of Infectious Diseases" domain, which includes adhering to guidelines for aseptic technique during invasive procedures. The Centers for Disease Control and Prevention (CDC) provides specific recommendations for skin antisepsis, as outlined in the
"Guidelines for the Prevention of Intravascular Catheter-Related Infections" (2017).
Option A, chlorhexidine, is the preferred antiseptic for skin preparation prior to intravascular device insertion in adults with no contraindications. Chlorhexidine, particularly in a 2% chlorhexidine gluconate (CHG) with
70% isopropyl alcohol solution, is recommended by the CDC due to its broad-spectrum antimicrobial activity, residual effect (which continues to kill bacteria after application), and superior efficacy compared to other agents in reducing CRBSI rates. Studies cited in the CDC guidelines demonstrate that chlorhexidine-based preparations significantly lower infection rates compared to povidone-iodine or alcohol alone, making it the gold standard for this procedure when tolerated by the patient.
Option B, povidone-iodine, is an alternative antiseptic that can be used for skin preparation. It is effective against a wide range of microorganisms and is often used when chlorhexidine is contraindicated (e.g., in patients with chlorhexidine allergy). However, its efficacy is less persistent than chlorhexidine, and it requires longer drying time, which can be a limitation in busy clinical settings. The CDC considers povidone-iodine a second-line option unless chlorhexidine is unavailable or unsuitable. Option C, alcohol (e.g., 70% isopropyl or ethyl alcohol), has rapid bactericidal activity but lacks a residual effect, making it less effective for prolonged protection during catheter dwell time. It is often used as a component of chlorhexidine-alcohol combinations but is not recommended as a standalone antiseptic for intravascular device insertion. Option D, antibiotic ointment, is not appropriate for skin preparation during insertion. Antibiotic ointments (e.g., bacitracin or mupirocin) are sometimes applied to catheter sites post-insertion to prevent infection, but their use is discouraged by the CDC due to the risk of promoting antibiotic resistance and fungal infections, and they are not classified as antiseptics for initial skin antisepsis.
The CBIC Practice Analysis (2022) supports the adoption of CDC-recommended practices, and the 2017 CDC guidelines explicitly state that chlorhexidine-based preparations with alcohol should be used for skin antisepsis unless contraindicated. For a patient with no contraindications, the infection preventionist should suggest chlorhexidine to optimize patient safety and align with best practices.
References:
* CBIC Practice Analysis, 2022.
* CDC Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2017.
NEW QUESTION # 249
......
If you like to practice CIC exam dumps on paper, you should choose us. Our CIC PDF version is printable, and you can print them into hard one and take some notes on them. Therefore you can study in anytime and at anyplace. Besides, free demo is available for CIC PDF version, and you can have a try before buying. After your payment, you can receive the downloading link and password for CIC Exam Dumps within ten minutes, and if you don’t receive, you can contact us, we will solve the problem for you as quickly as possible.
Latest CIC Test Camp: https://www.edudump.com/exams/CBIC/CIC/
P.S. Free & New CIC dumps are available on Google Drive shared by EduDump: https://drive.google.com/open?id=1vg75qVCoCJwOJQyQCAPRLbPP7Pa7UDBr